CIM
BNGO icon

CIM Investment Management’s Bionano Genomics BNGO Stock Holding History

CIM Investment Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-72
Closed -$26.5K – 279
2023
Q2 		$26.5K Hold
72
– – 0.01% 274
2023
Q1 		$48.2K Buy
72
+2
+3% +$1.78K 0.02% 260
2022
Q4 		$61.2K Buy
70
+26
+59% +$32.7K 0.02% 240
2022
Q3 		$49K Hold
44
– – 0.02% 221
2022
Q2 		$37K Hold
44
– – 0.02% 231
2022
Q1 		$69K Sell
44
-6
-12% -$8.1K 0.02% 248
2021
Q4 		$89K Hold
50
– – 0.03% 296
2021
Q3 		$164K Buy
50
+23
+85% +$80.4K 0.05% 294
2021
Q2 		$118K Buy
+27
New +$107K 0.04% 295

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CIM Investment Management's BNGO Position: Q3 2023 in Review

CIM Investment Management sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 72 shares — an estimated $26.5K sold.

CIM Investment Management first reported a position in BNGO in Q2 2021 and held it in 9 quarters. The position peaked at $164K in Q3 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • CIM Investment Management reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • CIM Investment Management sold 72 Bionano Genomics shares in Q3 2023, an estimated $26.5K.
  • CIM Investment Management first reported a position in Bionano Genomics in Q2 2021 and held it in 9 quarters.
  • CIM Investment Management's Bionano Genomics position peaked at $164K in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on CIM Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.